Gut and Tumor Microbiome in Patients With Advanced ER-positive and HER2-negative Breast Cancer or Advanced Melanoma Undergoing PD-1 Checkpoint Inhibitor Therapy.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Melanoma
Interventions: OTHER: Observation
Sponsor: BioCorteX Inc
Collaborators: Tempus AI